CC0000: The applicant claims color as a feature of the mark, namely, blue, white and yellow.
D10000: "(LEVOCETIRIZINE HCI")
DM0000: The mark consists of the literal element "XYZAL" written in blue with a yellow outline, the literal element "(levocetirizine HCI)" written in blue below XYZAL, and to the left of the literal elements, there is a blue wall with yellow circles to the left.
GS0051: Pharmaceutical products for the treatment of respiratory diseases, namely anti-allergic and anti-asmatic decongestants
Case File Event Statements
5/18/2009 - 16 years ago
25 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
5/18/2009 - 16 years ago
24 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
2/18/2009 - 16 years ago
23 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
9/9/2008 - 17 years ago
22 - EXTENSION 2 GRANTEDType:EX2G
8/28/2008 - 17 years ago
21 - EXTENSION 2 FILEDType:EXT2
9/9/2008 - 17 years ago
20 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
8/28/2008 - 17 years ago
19 - PAPER RECEIVEDType:MAIL
4/22/2008 - 17 years ago
18 - EXTENSION 1 GRANTEDType:EX1G
4/3/2008 - 17 years ago
17 - EXTENSION 1 FILEDType:EXT1
4/3/2008 - 17 years ago
16 - PAPER RECEIVEDType:MAIL
10/16/2007 - 18 years ago
15 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
7/24/2007 - 18 years ago
14 - PUBLISHED FOR OPPOSITIONType:PUBO
7/11/2007 - 18 years ago
13 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLYType:ASCK
7/4/2007 - 18 years ago
12 - NOTICE OF PUBLICATIONType:NPUB
5/7/2007 - 18 years ago
11 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
5/7/2007 - 18 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
5/3/2007 - 18 years ago
9 - AMENDMENT FROM APPLICANT ENTEREDType:ACEC
5/3/2007 - 18 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA